| Identification | Back Directory | [Name]
Sulfasymazine | [CAS]
1984-94-7 | [Synonyms]
Sulfasymazine
4-amino-N-(4,6-diethyl-s-triazin-2-yl)benzenesulfonamide
4-amino-N-(4,6-diethyl-1,3,5-triazin-2-yl)benzenesulfonamide
4-azanyl-N-(4,6-diethyl-1,3,5-triazin-2-yl)benzenesulfonamide
Benzenesulfonamide, 4-amino-N-(4,6-diethyl-1,3,5-triazin-2-yl)- | [Molecular Formula]
C13H17N5O2S | [MDL Number]
MFCD00865018 | [MOL File]
1984-94-7.mol | [Molecular Weight]
307.37 |
| Chemical Properties | Back Directory | [Melting point ]
186.5-187.5° (Taft); 190-190.5° (Bader) | [Boiling point ]
573.8±52.0 °C(Predicted) | [density ]
1.359±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
pKa (30% acetone) = 5.4(at 25℃) |
| Hazard Information | Back Directory | [Uses]
Sulfasymazine is a sulfonamide agent and displays antibacterial properties. | [Definition]
ChEBI: Sulfasymazine is a member of benzenes and a sulfonamide. | [in vivo]
Sulfasymazine is a sulfonamide drug and displays antibacterial properties. On a dosage basis, Sulfasymazine is from 2 to 10 times more potent than sulfisoxazole; on a blood level basis, Sulfasymazine potency ranges from 0.3 to 1. In acute toxicity studies in mice, the sodium salt of Sulfasymazine is tolerated at 2000 mg/kg orally, and at 1000 mg/kg intraperitoneally[1]. | [storage]
Store at -20°C | [References]
[1] Redin GS, et al. An evaluation of sulfasymazine in infections in mice. Chemotherapy. 1966;11(6):309-14. DOI:10.1159/000220466 |
|
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|